The effect of oral low molecular weight liquid hyaluronic acid combination with glucosamine and chondroitin on knee osteoarthritis patients with mild knee pain
Authors:
Open Access
- 5 February 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Medicine
- Vol. 100 (5) , e24252
Abstract
Background: The popularity of dietary supplements for knee osteoarthritis (OA) management is on the rise; however, their effects are still debated. Methods: This study aimed to investigate the effect of an oral low molecular weight liquid hyaluronic acid supplement in the treatment of knee OA patients with mild knee pain (visual analogue scale [VAS] ≤ 3) in Taiwan population. This was a randomized, double-blind, placebo-controlled study. Forty-seven subjects were enrolled and randomly allocated to either the A+HA or the placebo groups. The subjects were required to drink a bottle contained 20 mL of A+HA or placebo daily throughout an 8-week study period. The efficacy was assessed by using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and the 36-item Short Form Survey (SF-36). Results: At Week 8, significant reductions from baseline in the WOMAC pain (–2.6 ± 1.68, P < .0001), stiffness (–1.2 ± 1.50, P = .007), physical function (–5.8 ± 4.39, P < .0001), and total (–9.4 ± 5.82, P < .0001) scores were observed in the A+HA group but not in the placebo group. Significant differences in the mean change of WOMAC scores from baseline at Week 8 between groups were detected (P < .01). At Week 8, the A+HA group also showed significant improvements in SF-36 physical functioning (2.7 ± 3.10, P = .001) and bodily pain (0.7 ± 1.50, P < .05) domains. Although the A+HA group had a higher increase in the SF-36 total score than the placebo group but the difference was not statistically significant (2.1 ± 12.75 vs 0.3 ± 19.66, P = .12). Conclusions: Oral administration of low molecular weight liquid HA appeared to be effective for knee OA patients with mild knee pain (VAS ≤ 3) in the relief of knee OA symptoms, particularly in pain and physical function. Clinical Trial Registration: NCT04352322.Keywords
Funding Information
- Top Pharm & Medicalware, Taiwan (no)
This publication has 24 references indexed in Scilit:
- The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 studyAnnals of the Rheumatic Diseases, 2014
- Quality of Life in Patients with Knee Osteoarthritis: A Commentary on Nonsurgical and Surgical TreatmentsThe Open Orthopaedics Journal, 2013
- US-Approved Intra-Articular Hyaluronic Acid Injections are Safe and Effective in Patients with Knee Osteoarthritis: Systematic Review and Meta-Analysis of Randomized, Saline-Controlled TrialsClinical Medicine Insights: Arthritis and Musculoskeletal Disorders, 2013
- Difficulties swallowing solid oral dosage forms in a general practice population: prevalence, causes, and relationship to dosage formsEuropean Journal of Clinical Pharmacology, 2012
- Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapyInternational Journal of Pharmaceutics, 2012
- Oral Administration of Polymer Hyaluronic Acid Alleviates Symptoms of Knee Osteoarthritis: A Double-Blind, Placebo-Controlled Study over a 12-Month PeriodThe Scientific World Journal, 2012
- Medicine administration errors in patients with dysphagia in secondary care: a multi-centre observational studyJournal of Advanced Nursing, 2011
- Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint®) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trialNutrition Journal, 2008
- Glucosamine, Chondroitin Sulfate, and the Two in Combination for Painful Knee OsteoarthritisNew England Journal of Medicine, 2006
- Medication administration in nursing homesNursing Standard, 2002